Skip to main content
Erschienen in: Breast Cancer Research and Treatment 3/2008

01.10.2008 | Epidemiology

Differences in breast cancer biological characteristics between ethnic groups in New Zealand

verfasst von: M. K. Weston, D. P. Moss, J. Stewart, A. G. Hill

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 3/2008

Einloggen, um Zugang zu erhalten

Abstract

Objective To investigate differences in breast cancer biological characteristics between ethnic groups in Auckland, New Zealand. Design Prospective cohort study. Setting Auckland Breast Cancer Study Group. Participants All people diagnosed with breast cancer in the greater Auckland area between 2000 and 2005 who agreed to participate (1,577). Main outcome measures Size, grade, lymph node status, estrogen receptor (ER), progesterone receptor (PR), lymphovascular invasion (LVI), grade allowing for size, all compared with ethnicity. Results NZ Maori and Pacific Island participants had larger tumours (P < 0.0001), higher grade tumours (P < 0.0001) with more involved lymph nodes (P < 0.0001). When allowing for size, there was still an indication that NZ Maori people had higher grade tumours (P = 0.03). There was no difference in ER, PR and LVI between ethnic groups. Conclusion These data suggest differences in tumour biology related to ethnicity in the Auckland population and this has implications for breast cancer screening and management.
Literatur
1.
Zurück zum Zitat Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K et al (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295:2492–2502PubMedCrossRef Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K et al (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295:2492–2502PubMedCrossRef
2.
Zurück zum Zitat Cunningham JE, Butler WM (2004) Racial disparities in female breast cancer in South Carolina: clinical evidence for a biological basis. Breast Cancer Res Treat 88:161–176PubMedCrossRef Cunningham JE, Butler WM (2004) Racial disparities in female breast cancer in South Carolina: clinical evidence for a biological basis. Breast Cancer Res Treat 88:161–176PubMedCrossRef
3.
Zurück zum Zitat Hayanga AJ, Newman LA (2007) Investigating the phenotypes and genotypes of breast cancer in women with African ancestry: the need for more genetic epidemiology. Surg Clin North Am 87:551–568PubMedCrossRef Hayanga AJ, Newman LA (2007) Investigating the phenotypes and genotypes of breast cancer in women with African ancestry: the need for more genetic epidemiology. Surg Clin North Am 87:551–568PubMedCrossRef
4.
Zurück zum Zitat Masi CM, Olopade OI (2005) Racial and ethnic disparities in breast cancer: a multilevel perspective. Med Clin North Am 89:753–770PubMedCrossRef Masi CM, Olopade OI (2005) Racial and ethnic disparities in breast cancer: a multilevel perspective. Med Clin North Am 89:753–770PubMedCrossRef
6.
Zurück zum Zitat Lethaby AE, Mason BH, Holdaway IM, Kay RG (1992) Age and ethnicity as prognostic factors influencing overall survival in breast cancer patients in the Auckland region. Auckland Breast Cancer Study Group. N Z Med J 105:485–488PubMed Lethaby AE, Mason BH, Holdaway IM, Kay RG (1992) Age and ethnicity as prognostic factors influencing overall survival in breast cancer patients in the Auckland region. Auckland Breast Cancer Study Group. N Z Med J 105:485–488PubMed
7.
Zurück zum Zitat Lawes CM, Tukuitonga CF, Scragg RK (1999) The epidemiology of breast cancer in Pacific women in New Zealand. N Z Med J 112:354–357PubMed Lawes CM, Tukuitonga CF, Scragg RK (1999) The epidemiology of breast cancer in Pacific women in New Zealand. N Z Med J 112:354–357PubMed
8.
Zurück zum Zitat Curtis E, Wright C, Wall M (2005) The epidemiology of breast cancer in Maori women in Aotearoa New Zealand: implication for screening and treatment. N Z Med J 118–1209/1298 Curtis E, Wright C, Wall M (2005) The epidemiology of breast cancer in Maori women in Aotearoa New Zealand: implication for screening and treatment. N Z Med J 118–1209/1298
9.
Zurück zum Zitat Furberg H, Millikan R, Dressler L, Newman B, Geradts J (2001) Tumor characteristics in African American and white women. Breast Cancer Res Treat 68:33–43PubMedCrossRef Furberg H, Millikan R, Dressler L, Newman B, Geradts J (2001) Tumor characteristics in African American and white women. Breast Cancer Res Treat 68:33–43PubMedCrossRef
10.
Zurück zum Zitat Newman PD, Mason BH, Holdaway IM, Kay RG, Arthur JF, Hitchcock GC (1992) Incidence and clinical features of breast cancer in the Auckland region. N Z Med J 105:117–120PubMed Newman PD, Mason BH, Holdaway IM, Kay RG, Arthur JF, Hitchcock GC (1992) Incidence and clinical features of breast cancer in the Auckland region. N Z Med J 105:117–120PubMed
11.
Zurück zum Zitat Lethaby AE, Mason BH, Holdaway IM, Kay RG (1992) Age and ethnicity as prognostic factors influencing overall survival in breast cancer patients in the Auckland region. N Z Med J 105:485–488PubMed Lethaby AE, Mason BH, Holdaway IM, Kay RG (1992) Age and ethnicity as prognostic factors influencing overall survival in breast cancer patients in the Auckland region. N Z Med J 105:485–488PubMed
12.
Zurück zum Zitat Pearce N, Foliaki S, Sporle A, Cunningham C (2004) Genetics, race, ethnicity and health. Br Med J 328:1070–1072CrossRef Pearce N, Foliaki S, Sporle A, Cunningham C (2004) Genetics, race, ethnicity and health. Br Med J 328:1070–1072CrossRef
13.
Zurück zum Zitat Anderson TJ, Waller M, Ellis IO, Bobrow L, Moss S (2004) Influence of annual mammography from age 40 on breast cancer pathology. Hum Pathol 35:1251–1259CrossRef Anderson TJ, Waller M, Ellis IO, Bobrow L, Moss S (2004) Influence of annual mammography from age 40 on breast cancer pathology. Hum Pathol 35:1251–1259CrossRef
14.
Zurück zum Zitat Korsching E, Packeisen J, Helms MW, Kersting C, Voss R, van Diest PJ et al (2004) Deciphering a subgroup of breast carcinomas with putative progression of grade during carcinogenesis revealed by comparative genomic hybridisation (CGH) and immunohistochemistry. Br J Cancer 90:1422–1428PubMedCrossRef Korsching E, Packeisen J, Helms MW, Kersting C, Voss R, van Diest PJ et al (2004) Deciphering a subgroup of breast carcinomas with putative progression of grade during carcinogenesis revealed by comparative genomic hybridisation (CGH) and immunohistochemistry. Br J Cancer 90:1422–1428PubMedCrossRef
Metadaten
Titel
Differences in breast cancer biological characteristics between ethnic groups in New Zealand
verfasst von
M. K. Weston
D. P. Moss
J. Stewart
A. G. Hill
Publikationsdatum
01.10.2008
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 3/2008
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-007-9813-3

Weitere Artikel der Ausgabe 3/2008

Breast Cancer Research and Treatment 3/2008 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.